What is GSK plc's Price/Sales Ratio?
- GSK plc's trailing twelve month (TTM) Price/Sales ratio is 1.95.
- GSK plc's annual Price/Sales ratio as of today is 1.75.
- GSK plc's quarterly Price/Sales ratio is 6.76.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess GSK plc's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 21.32
- Quarterly: 33.15
- TTM: 23.85
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 4.02
- Quarterly: 4.02
- TTM: 4.49
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 8.38
- Quarterly: 23.57
- TTM: 9.76
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: -0.44
- Quarterly: -0.04
- TTM: 7.39
These metrics provide insights into GSK plc's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
1.75
Quarterly Price/Sales Ratio
6.76
TTM Price/Sales Ratio
1.95
GSK plc Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
GSK plc Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 1.75 | 21.32 | 4.02 | 8.38 | -0.44 |
| 2023 | 1.94 | 11.92 | 4.40 | 8.68 | 0.00 |
| 2022 | 1.97 | 11.76 | 5.46 | 7.82 | -1.07 |
| 2021 | 1.52 | 11.85 | 3.45 | 6.54 | -2.44 |
| 2020 | 1.58 | 9.39 | 3.70 | 6.39 | 0.41 |
| 2019 | 2.11 | 15.31 | 5.93 | 8.87 | 0.56 |
| 2018 | 1.92 | 16.34 | 13.58 | 7.03 | 0.12 |
| 2017 | 1.73 | 34.08 | -767.86 | 7.55 | 0.55 |
| 2016 | 2.20 | 67.26 | 54.57 | 9.44 | -0.76 |
| 2015 | 2.24 | 6.36 | 10.48 | 20.86 | 0.03 |
Related Metrics
Explore detailed financial metrics and analysis for GSK.L.